Clinical trial
Health Impact Study of Aquatabs in Tamale, Ghana
NCT00252928 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00252928 |
|---|---|
| Title | Health Impact Study of Aquatabs in Tamale, Ghana |
| Official title | Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Medentech Industry Emory University Center for Global Safe Water NewEnergy University for Development Studies, Tamale, Ghana |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Other |
| Interventions | Sodium dichloroisocyanurate (NaDCC) tablets, Placebo |
| Enrollment | 240 |
| Start date | Jul 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Oct 30, 2007 |
| Countries | Ghana, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: